Report finds China targeted AstraZeneca in fraud probe over cancer treatment

SCMP | Nov. 4, 2024, 4:24 a.m. | Original
The pharmaceutical giant, whose China chief is now under investigation, was previously at the centre of insurance scam cases, report says.
Can Japan-China talks change course on North Korea’s alliance with Russia? China needs more ‘skilled talent’, and they deserve better pay, Premier Li Qiang urges